AARDVARK THERAPEUTICS INC. - COMMON STOCK

9.5300

26-August-25 13:45:00

15 minutes delayed

Stocks

+0.4900

+5.42%

Today's range

8.9400 - 9.7190

ISIN

N/A

Source

NASDAQ

Aardvark Therapeutics Reports Second Quarter 2025 Financial Results and Provides Pipeline and Business Updates

13 Aug 2025 13:10:00 By Nasdaq GlobeNewswire
Aardvark Therapeutics Announces ARD-201 Preclinical Obesity Data Showing Significant Weight Loss as a Monotherapy, Enhancement of GLP-1RA Therapy in Combination, and Effective Maintenance Following Discontinuation of GLP-1RA Therapy

12 Aug 2025 05:00:01 By Nasdaq GlobeNewswire
Aardvark Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)

18 Jul 2025 05:00:00 By Nasdaq GlobeNewswire
Aardvark Therapeutics to Join Prader-Willi Syndrome Community at the 2025 United in Hope Conference

24 Jun 2025 05:00:00 By Nasdaq GlobeNewswire
Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal Functions

19 May 2025 13:10:00 By Nasdaq GlobeNewswire
Aardvark Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights

14 May 2025 13:10:00 By Nasdaq GlobeNewswire
Aardvark Therapeutics to Present at Upcoming Investor Conferences in May

07 May 2025 13:05:00 By Nasdaq GlobeNewswire
Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights

31 Mar 2025 13:10:00 By Nasdaq GlobeNewswire

<<
<
1
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.